The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback